
The Medicines and Healthcare products Regulatory Agency (MHRA) has authorised an extension to the indication for Lynkuet (elinzanetant), allowing its …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

